Ultragenyx, a biopharmaceutical company based in Novato, CA, is committed to bringing novel products to patients for the treatment of rare and ultra-rare diseases, with a focus on serious and debilitating genetic diseases. Ultragenyx chose to implement DNAnexus Titan™, a unified NGS analysis platform, to bring data and pipelines together in one secure environment for streamlined multi-omics data analysis.